Editas Medicine (EDIT) Equity Ratio (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Equity Ratio data on file, last reported at 0.15 in Q4 2025.

• Quarterly Equity Ratio fell 62.78% year-over-year to 0.15 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.15 (down 62.78% YoY) and the FY2025 annual result came in at 0.15, down 62.78% from the prior year.
• Equity Ratio rose to 0.15 in Q4 2025 per EDIT's latest filing, from 0.07 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.82 in Q1 2022 and bottomed at 0.07 in Q3 2025.
• The 5-year median for Equity Ratio is 0.7 (2022), against an average of 0.6.
• The widest annual swing landed in 2021, when Equity Ratio soared 62.69%; it then slumped 87.56% in 2025.
• Tracing EDIT's Equity Ratio over 5 years: stood at 0.82 in 2021, then fell by 14.19% to 0.7 in 2022, then declined by 0.27% to 0.7 in 2023, then sank by 43.79% to 0.39 in 2024, then slumped by 62.78% to 0.15 in 2025.
• Per Business Quant, the three latest EDIT Equity Ratio figures stand at 0.15 (Q4 2025), 0.07 (Q3 2025), and 0.09 (Q2 2025).

Peer Comparison